Enveric Biosciences (NASDAQ:ENVB – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.30, Yahoo Finance reports.
Enveric Biosciences Stock Performance
Shares of NASDAQ:ENVB traded down $0.00 on Tuesday, hitting $0.52. 59,666 shares of the company were exchanged, compared to its average volume of 2,395,429. The company’s 50 day moving average price is $0.59 and its two-hundred day moving average price is $0.83. The firm has a market capitalization of $4.14 million, a price-to-earnings ratio of -0.08 and a beta of 0.74. Enveric Biosciences has a one year low of $0.41 and a one year high of $2.92.
Enveric Biosciences Company Profile
Further Reading
- Five stocks we like better than Enveric Biosciences
- Retail Stocks Investing, Explained
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- What is a Stock Market Index and How Do You Use Them?
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
- How to Capture the Benefits of Dividend Increases
- 3 Small Cap Stocks Insiders Are Actively Buying
Receive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.